Literature DB >> 13252181

Studies on the generalized Shwartzman reaction. VI. Production of the reaction by the synergistic action of endotoxin with three synthetic acidic polymers (sodium polyanethod sulfonate, dextran sulfate, and sodium polyvinyl alcohol sulfonate).

L THOMAS, J BRUNSON, R T SMITH.   

Abstract

Lesions indistinguishable from those of the generalized Shwartzman reaction occured in rabbits when a single intravenous injection of Gram-negative bacterial endotoxin was accompanied, or followed, by an injection of one of the following synthetic, heparin-like, acidic polymers-sodium polyanethol sulfonate, dextran sulfate, or sodium polyvinyl alcohol sulfonate. These reactions were produced by doses of polymer or of endotoxin which were without demonstrable effect when given singly. Heparin, in those similar to those previously shown to protect rabbits against the lesions of the generalized Shwartzman reaction, prevented the reaction to the combined injection of endotoxin and acidic polymers. Nitrogen mustard, which was previously shown to prevent the lesions of the generalized Shwartzman reaction from occurring after two intravenous injections of endotoxin, had no protective action against the lesions produced by the combined injection of endotoxin and polymer. Cortisone did not affect the reaction to endotoxin and polymer. The role of fibrinogen in the reaction under study is discussed in the paper which follows.

Entities:  

Keywords:  ALLERGY/experimental; ANTICOAGULANTS/effects; BIOLOGICAL PRODUCTS; DEXTRAN/effects; VINYL COMPOUNDS/effects

Mesh:

Substances:

Year:  1955        PMID: 13252181      PMCID: PMC2136513          DOI: 10.1084/jem.102.3.249

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Morphologic changes in rabbits following the intravenous administration of meningococcal toxin. II. Two appropriately spaced injections; the rôle of fibrinoid in the generalized Shwartzman reaction.

Authors:  J G BRUNSON; L THOMAS; C N GAMBLE
Journal:  Am J Pathol       Date:  1955 Jul-Aug       Impact factor: 4.307

2.  Morphologic changes in rabbits following the intravenous administration of meningococcal toxin. III. The effects produced by endotoxin in association with certain high molecular weight acidic polymers.

Authors:  J G BRUNSON; R L DAVIS; L THOMAS
Journal:  Am J Pathol       Date:  1955 Jul-Aug       Impact factor: 4.307

3.  Effect of cortisone on response to endotoxin in mature rabbits.

Authors:  L THOMAS; R T SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

4.  Influence of age upon response to meningococcal endotoxin in rabbits.

Authors:  R T SMITH; L THOMAS
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

5.  Intra-capillary precipitates produced in rabbits by means of sodium polyanetholsulfonate.

Authors:  R HAUSMAN; P M DREYFUS
Journal:  AMA Arch Pathol       Date:  1953-12

6.  The biological behaviour of a new synthetic anticoagulant (dextran sulphate) possessing heparin-like properties.

Authors:  K W WALTON
Journal:  Br J Pharmacol Chemother       Date:  1952-09

7.  The effect of cortisone on the Shwartzman reaction; the production of lesions resembling the dermal and generalized Shwartzman reactions by a single injection of bacterial toxin in cortisone-treated rabbits.

Authors:  L THOMAS; R A GOOD
Journal:  J Exp Med       Date:  1952-04       Impact factor: 14.307

8.  Studies on the generalized Shwartzman reaction. III. Lesions of the myocardium and coronary arteries accompanying the reaction in rabbits prepared by infection with group A streptococci.

Authors:  L THOMAS; F W DENNY; J FLOYD
Journal:  J Exp Med       Date:  1953-05       Impact factor: 14.307

9.  Studies on the generalized Shwartzman reaction. IV. Prevention of the local and generalized Shwartzman reactions with heparin.

Authors:  R A GOOD; L THOMAS
Journal:  J Exp Med       Date:  1953-06       Impact factor: 14.307

10.  Studies on the generalized Shwartzman reaction: I. General observations concerning the phenomenon.

Authors:  L THOMAS; R A GOOD
Journal:  J Exp Med       Date:  1952-12       Impact factor: 14.307

View more
  18 in total

1.  SULFATED MUCOPOLYSACCHARIDE AND BASIC PROTEIN IN CERTAIN GRANULES OF CIRCULATING HETEROPHILS OF RABBITS DURING ENDOTOXIN-INDUCED LEUKOCYTOSIS.

Authors:  R G HORN; S S SPICER
Journal:  Am J Pathol       Date:  1964-06       Impact factor: 4.307

Review 2.  [ON THE GENERALIZED SHWARTZMAN PHENOMENON IN ABORTION].

Authors:  G ADEBAHR
Journal:  Dtsch Z Gesamte Gerichtl Med       Date:  1963-08-20

3.  SULFATED MUCOPOLYSACCHARIDE IN FIBRINOID GLOMERULAR OCCLUSIONS OF THE GENERALIZED SHWARTZMAN REACTION.

Authors:  R G HORN; S S SPICER
Journal:  Am J Pathol       Date:  1965-02       Impact factor: 4.307

4.  [Production of the Shwartzman phenomenon by polysaccharides in the rabbit conjunctiva].

Authors:  W JAEGER; H HONEGGER
Journal:  Albrecht Von Graefes Arch Ophthalmol       Date:  1960

5.  Studies in experimental endocarditis. I. Production of valvular lesions by mechanisms not involving infection or sensitivity factors.

Authors:  A A ANGRIST; M OKA; K NAKAO; J MARQUISS
Journal:  Am J Pathol       Date:  1960-02       Impact factor: 4.307

6.  [On the Sanarelli-Shwartzman phenomenon (so-called generalized Shwartzman phenomenon) in man].

Authors:  A BOHLE; H J KRECKE
Journal:  Klin Wochenschr       Date:  1959-08-01

7.  [Mechanisms of nonspecific infection resistance].

Authors:  D BOHME
Journal:  Klin Wochenschr       Date:  1958-09-15

8.  A heparin-precipitable fraction of human plasma. I. Isolation and characterization of the fraction.

Authors:  R T SMITH; R W VON KORFF
Journal:  J Clin Invest       Date:  1957-04       Impact factor: 14.808

9.  Streptococcal cardiac lesions in rabbits.

Authors:  J G BRUNSON; P E FEHR; R L DAVIS
Journal:  Am J Pathol       Date:  1957 Sep-Oct       Impact factor: 4.307

10.  Plasmanate: a new plasma substitute for pediatric therapy.

Authors:  T C COCK; C M BINGER; J L DENNIS
Journal:  Calif Med       Date:  1958-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.